Gordon Parry, Ph.D. has been promoted to the position of vice president, R&D, oncology, Monogram Biosciences, Inc. Dr. Parry will have responsibility for the company’s oncology research and development programs, including the further development of Monogram’s VeraTag technology platform and the first product based on that platform, the HERMark Breast Cancer Assay. He will continue to manage the oncology R&D team. Dr. Parry joined the company in 2007 as senior director ...